In the January 2016 edition of Financier Worldwide, Dr. Gregory K. Bell discusses how mergers and acquisitions can create shareholder value in the life sciences sector. The roundtable discussion is moderated by James C. Greenwood, President and CEO of the Biotechnology Innovation Organization (BIO). To read the article, click the link below.
New vertical merger test
In vertical mergers, antitrust agencies often focus on the merging firms’ incentives to foreclose inputs to rivals when analyzing competitive effects. Less...